Avidity Biosciences, Inc. Profile Avatar - Palmy Investing

Avidity Biosciences, Inc.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead produc…

Biotechnology
US, San Diego [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Avidity Biosciences, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Avidity Biosciences, Inc. can't present revenue by segment

End of RNA's Analysis
CIK: 1599901 CUSIP: 05370A108 ISIN: US05370A1088 LEI: - UEI: -
Secondary Listings
RNA has no secondary listings inside our databases.